Search Results

(3a’R,4’S,5’S,6a’S)-5′-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2′(1’H)-pentalene]-4′-carboxamide Please inquire  | Purity Not Available

BOC Sciences

(3a’R,4’S,5’S,6a’S)-5′-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2′(1’H)-pentalene]-4′-carboxamide is an intermediate in the synthesis of Iloprost (I267300),a synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, raynaud’s phenomenon and ischemia.

More Information Supplier Page

(3a’R,6a’S)-5,5-Dimethyltetrahydro-1’H-spiro[[1,3]dioxane-2,2′-pentalen]-5′(3’H)-one Please inquire  | Purity Not Available

BOC Sciences

(3a’R,6a’S)-5,5-Dimethyltetrahydro-1’H-spiro[[1,3]dioxane-2,2′-pentalen]-5′(3’H)-one is an intermediate in the synthesis of Iloprost (I267300),a synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, raynaud’s phenomenon and ischemia.

More Information Supplier Page

(3a’S,4’R,5’R,6a’R)-5′-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2′(1’H)-pentalene]-4′-carboxamide Please inquire  | Purity Not Available

BOC Sciences

(3a’S,4’R,5’R,6a’R)-5′-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-N-[(1R)-2-hydroxy-1-phenylethyl]-5,5-dimethyl-spiro[1,3-dioxane-2,2′(1’H)-pentalene]-4′-carboxamide is an intermediate in the synthesis of Iloprost (I267300),a synthetic analogue of Prostacyclin (PGI2) used to treat pulmonary arterial hypertension (PAH), scleroderma, raynaud’s phenomenon and ischemia.

More Information Supplier Page